Oral Mucositis Therapeutics Pipeline Analysis 2017

19/lug/2017 11:07:04 P&S Market Research Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The study Analyzed That the  oral mucositis therapeutics pipeline  comprises Approximately 18 drug candidates in different stages of development. Oral mucositis is the most common complication of chemotherapy in cancer patients. It causes damage to the mucosal lining of the mouth Which results in formation of ulcers. It can result in several problems That includes severe pain in the mouth, nutritional problems as a result of inability to eat and Increased risk of infection two to open sores in the lining.

 

Access Report Overview: https://www.psmarketresearch.com/market-analysis/oral-mucositis-therapeutics-pipeline-analysis

Oragenics, Inc. is using ActoBiotics technology platform for the development of Their drug candidates for the treatment of oral mucositis. The technology platform Produces a new class of orally delivered biopharmaceuticals. Through ActoBiotics technology platform, food-grade microbes are engineered to generate biologically contained ActoBiotics therapeutics for in situ expression and secretion of novel proteins and peptides including cytokines, enzymes, hormones and monoclonal antibodies Within the body.

The research found That Also various companies received Designations from the USFDA for the development of the drugs in the oral mucositis therapeutics pipeline. In November 2016, the US FDA granted Fast Track designation to AG013 for the treatment of oral mucositis.

Explore Reports Sample at: https://www.psmarketresearch.com/market-analysis/oral-mucositis-therapeutics-pipeline-analysis/report-sample

Some of the other key players in developing drugs for the treatment of oral mucositis include Daewoong Pharmaceutical Co., Ltd., Cellceutix Corporation, Soligenix, Inc. and others.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl